MMP2 and MMP9 contribute to lung ischemia–reperfusion injury via promoting pyroptosis in mice

Author:

Zhou Peng,Song Nai-Cheng,Zheng Zhi-Kun,Li Yi-Qing,Li Jin-Song

Abstract

Abstract Background Lung ischemia–reperfusion injury (LIRI) is a cause of poor prognosis in several lung diseases and after lung transplantation. In LIRI, matrix metalloproteinases and pyroptosis indicators change in parallel, both of them involvement of inflammatory modulation, but it is unclear whether they are related to each other. Methods We analyzed the matrix metalloproteinases (MMPs) changes from RNA sequencing (RNA-Seq) data of human transplantation and rat ischemia–reperfusion lung tissues in the Group on Earth Observations (GEO) database. Then established the mouse LIRI model to validate the changes. Further, the severity of lung injury was measured after intervening the matrix metalloproteinases changes with their selective inhibitor during Lung ischemia–reperfusion. Meanwhile, lung, pyroptosis was assessed by assaying the activity of Caspase-1 and interleukin 1β (IL-1β) before and after intervening the matrix metalloproteinases changes. Results The RNA-Seq data revealed that matrix metallopeptidase 2 (MMP2), matrix metallopeptidase 9 (MMP9) mRNA expression was elevated both in human lung transplantation and rat lung ischemia–reperfusion tissues, consistent with the change in our mouse model. At the same time, the activity of Caspase-1 and IL-1β were increased after LIRI. While, the lung injury was attenuated for the use of MMP2 and MMP9 selective inhibitor SB-3CT. Likewise, lung pyroptosis alleviated when treatment the mice with SB-3CT in LIRI. Conclusion We conclude that MMP2 and MMP9 are involved in the process of LIRI, the mechanism of which is related to the promotion of lung pyroptosis.

Funder

Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Reference53 articles.

1. Sharma A, Stone M, Lau C, et al. Pulmonary transplantation and ischemia-reperfusion injury. Top Thoracic Surg. 2012;3:401.

2. Ng C, Wan S, Yim A, et al. Pulmonary dysfunction after cardiac surgery. Chest J. 2002;121:1269–312.

3. Zhang J, Wang J, Zheng Z, et al. Participation of autophagy in lung ischemia-reperfusion injury in vivo. J Surg Res. 2013;182:e79-87.

4. Shimamoto A, Pohlman T, Shomura S, et al. Toll-like receptor 4 mediates lung ischemia-reperfusion injury. Ann Thorac Surg. 2006;2:201–2023.

5. Ng C, Wan S, Yim A. Pulmonary ischemia-reperfusion injury: role of apoptosis. Eur Respir J. 2005;25:356–63.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3